Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Usher III Initiative prepares novel compounds for Usher syndrome

Nov. 29, 2012

Phase IIb trial of AM-111 in severe hearing loss meets primary endpoint

Nov. 15, 2012

Recruitment complete in first stage of TACTT1 study

Aug. 14, 2012

Auris Medical completes enrollment in AM-111 trial

April 24, 2012

Study reveals new therapeutic use for phosphodiesterase 5 inhibitors

Feb. 24, 2012

Pergamum begins phase II DPK-060 trial in outer ear infections

Jan. 17, 2012

JNK inhibitor prevents hearing loss due to transient cochlear ischemia in preclinical study

Jan. 12, 2012

Phage Pharmaceuticals submits IND for first-in-class therapeutic

Dec. 27, 2011

Second milestone reached in GenVec/Novartis collaboration

Dec. 7, 2011

Peptide P-13 ameliorates experimental otitis media

July 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...